Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-27 Purchase | 2024-08-29 4:30 pm | ENDRA Life Sciences Inc. | NDRA | UBS Group AG 10% Owner | 3,715 | $0.5523 | $2,052 | 146,012 (Indirect) | View |
| 2023-05-18 Purchase | 2023-05-22 07:30 am | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 15,000 | $1.65 | $24,750 | 34,139 (Direct) | View |
| 2023-05-02 Purchase | 2023-05-03 4:07 pm | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 83,333 | $1.2 | $100,000 | 144,101 (Direct) | View |
| 2022-12-09 Purchase | 2022-12-13 4:00 pm | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 1,500 | $3.4 | $5,100 | 19,139 (Direct) | View |
| 2022-11-23 Purchase | 2022-11-28 5:00 pm | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 10,000 | $0.17 | $1,700 | 162,857 (Direct) | View |
| 2022-08-22 Purchase | 2022-08-24 08:57 am | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 20,000 | $0.27 | $5,400 | 352,775 (Direct) | View |
| 2022-08-22 Purchase | 2022-08-24 08:55 am | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 20,000 | $0.26 | $5,200 | 152,857 (Direct) | View |
| 2022-05-26 Purchase | 2022-05-31 08:46 am | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 25,000 | $0.21 | $5,250 | 332,775 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-23 4:30 pm | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 25,000 | $0.22 | $5,500 | 307,775 (Direct) | View |
| 2022-05-17 Purchase | 2022-05-19 07:00 am | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer | 5,100 | $0.19 | $969 | 97,191 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-17 4:14 pm | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 100,000 | $0.1963 | $19,630 | 132,857 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-11 Option Award | 2025-07-01 06:26 am | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 5,384 | $0 | 5,385 (Direct) | View |
| 2025-06-11 Option Award | 2025-07-01 06:25 am | N/A N/A | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 5,384 | $0 | 5,386 (Direct) | View |
| 2025-06-11 Option Award | 2025-07-01 06:25 am | N/A N/A | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 5,384 | $0 | 5,443 (Direct) | View |
Ownership(A) | 2024-09-05 2:47 pm | N/A N/A | ENDRA Life Sciences Inc. | NDRA | UBS Group AG Market maker/broker-dealer | 0 | $0 | 146,012 (Indirect) | View |
Ownership | 2024-08-29 12:11 pm | N/A N/A | ENDRA Life Sciences Inc. | NDRA | UBS Group AG 10% Owner | 0 | $0 | 146,012 (Indirect) | View |
| 2024-01-02 Option Award | 2024-02-23 5:00 pm | N/A 2034-01-02 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 600 | $0 | 600 (Direct) | View |
| 2024-01-02 Option Award | 2024-02-23 5:00 pm | N/A 2034-01-02 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 600 | $0 | 600 (Direct) | View |
| 2024-01-02 Option Award | 2024-02-23 5:00 pm | N/A 2034-01-02 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 600 | $0 | 600 (Direct) | View |
| 2024-01-02 Option Award | 2024-02-23 5:00 pm | N/A 2034-01-02 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 600 | $0 | 600 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 6,746 | $0 | 6,746 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 9,621 | $0 | 9,621 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 9,634 | $0 | 9,634 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 9,621 | $0 | 9,621 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 68,066 | $0 | 68,066 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 8:30 pm | N/A 2033-01-30 | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer | 69,531 | $0 | 69,531 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:16 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Maloberti Renaud Bertrand Chief Commercial Officer | 186,430 | $0 | 186,430 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Thornton Michael Milos Chief Technology Officer | 698,102 | $0 | 698,102 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Michelon Francois Roger Chief Executive Officer | 713,132 | $0 | 713,132 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 109,323 | $0 | 109,323 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 109,323 | $0 | 109,323 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Pestrikova Irina Senior Director, Finance | 41,500 | $0 | 41,500 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 109,492 | $0 | 109,492 (Direct) | View |
| 2022-03-28 Option Award | 2022-03-30 5:15 pm | N/A 2032-03-28 | ENDRA Life Sciences Inc. | NDRA | Basenese Lou Director | 74,500 | $0 | 74,500 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:07 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | Tokman Alexander Y Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:06 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | DIGIANDOMENICO ANTHONY Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-04 5:05 pm | 2023-01-03 2032-01-03 | ENDRA Life Sciences Inc. | NDRA | Harsh Michael Director | 12,000 | $0 | 12,000 (Direct) | View |